Ariadna Giró-Perafita (A Giro-Perafita)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Transforming Growth Factor

Transcription Factor

Patient Reported Outcomes

Chemotherapy Induced

Top Venues

NPJ breast cancer

Molecules (Basel, Switzerland)

New York University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

New York University Oct 01 2016

United States

Postdoctoral researcher :: Cancer Center

Publications

Ariadna Giró-Perafita, L Luo, A Khodadadi-Jamayran, M Thompson, B Akgol Oksuz, Aristotelis Tsirigos, B D Dynlacht, I Sánchez, F J Esteva
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer. NPJ breast cancer 6 (2020)
Ariadna Giró-Perafita, Marc Rabionet, Marta Planas, Lidia Feliu, Joaquim Ciurana, Santiago Ruiz-Martínez, Teresa Puig
EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models. Molecules (Basel, Switzerland) 24 (6) (2019)